Abeona Therapeutics (NASDAQ: ABEO) net income
Abeona Therapeutics reported a net profit of $71.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $63.7m. Its net margin was 1,223.1%. Earnings per share were $1.34.
Fiscal 2025 is the highest of the 10 fiscal years on record for Abeona Therapeutics. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $71.2m | — | 1,223.1% | $1.34 |
| 2024 | −$63.7m | — | −1,501.0% | −$1.55 |
| 2023 | −$54.2m | — | −1,548.2% | −$2.53 |
| 2022 | −$39.7m | — | −2,807.4% | −$5.53 |
| 2021 | −$84.9m | — | −2,831.2% | −$21.57 |
| 2020 | −$84.2m | — | −842.3% | — |
| 2019 | −$76.3m | — | — | — |
| 2018 | −$56.7m | — | −1,890.3% | — |
| 2017 | −$27.3m | — | −3,263.9% | — |
| 2016 | −$21.9m | — | −2,460.4% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Abeona Therapeutics net income compared with its sector
By net income for its latest fiscal year, Abeona Therapeutics ranks 122nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Abeona Therapeutics, 1,223.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 120th | Sotera Health | $77.9m | 6.7% |
| 121st | Amneal Pharmaceuticals | $72.1m | 2.4% |
| 122nd | Abeona Therapeutics | $71.2m | 1,223.1% |
| 123rd | Nutex Health | $70.8m | 8.1% |
| 124th | UFP Technologies | $68.3m | 11.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Abeona Therapeutics
- How much did Abeona Therapeutics earn in fiscal 2025?
- Abeona Therapeutics reported a net profit of $71.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $63.7m.
- What are the earnings per share of Abeona Therapeutics?
- They were $1.34 in fiscal 2025, compared with −$1.55 in fiscal 2024.
- What is the net margin of Abeona Therapeutics?
- In fiscal 2025 its net profit was 1,223.1% of its revenue.
- What was the most profitable year for Abeona Therapeutics?
- Of its last 10 fiscal years, fiscal 2025, with $71.2m.
- Where does Abeona Therapeutics rank in its sector by net income?
- It ranks 122nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Abeona Therapeutics come from?
- From the annual report (Form 10-K) that Abeona Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Abeona Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Abeona Therapeutics: the Abeona Therapeutics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.